Citation: Mj. Alter et Cn. Shapiro, Epidemiology and prevention of chronic hepatitis B and C in North and South America, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 3-8
Authors:
Alvarado-Esquivel, C
Wyseur, A
Herrera-Ortiz, FD
Ruiz-Maya, L
Ruiz-Astorga, R
Zarate-Aguilar, A
Carrillo-Maravilla, E
Herrera-Luna, R
Morales-Macedo, MD
Maertens, G
Stuyver, L
Citation: C. Alvarado-esquivel et al., Hepatitis B and C virus infections in Mexico: genotypes and geographical distribution in blood donors and patients with liver disease, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 35-41
Citation: M. Rosenstraus et al., Utility of hepatitis virus nucleic acid assays in therapeutic drug trials, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 115-127
Citation: Jd. Morrey et al., Transgenic mice as a chemotherapeutic model for hepatitis B virus infection, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 161-170
Authors:
Tennant, BC
Peek, SF
Tochkov, IA
Baldwin, BH
Hornbuckle, WE
Korba, BE
Cote, PJ
Gerin, JL
Citation: Bc. Tennant et al., The woodchuck in preclinical assessment of therapy for hepatitis B virus infection, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 171-176
Authors:
Watts, AM
Stanley, JR
Shearer, MH
Kennedy, RC
Citation: Am. Watts et al., Maternal and foetal vaccination strategies for hepatitis B surface antigenin non-human primate models: evaluation of therapeutic modalities during pregnancy, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 185-193
Authors:
Gangemi, JD
Korba, BE
Tennant, BC
Gerin, JL
Cote, PJ
Ueda, H
Jay, G
Citation: Jd. Gangemi et al., Antiviral and anti-proliferative activities of a interferons in experimental hepatitis B virus infections, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 195-203
Authors:
Blight, KJ
Kolykhalov, AA
Reed, KE
Agapov, EV
Rice, CM
Citation: Kj. Blight et al., Molecular virology of hepatitis C virus: an update with respect to potential antiviral targets, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 207-217